ARCHITECT C8000
Report
- Report Number
- 1628664-2008-00091
- Event Type
- Malfunction
- Date Received
- April 16, 2008
- Date of Event
- March 26, 2008
- Report Date
- March 26, 2008
- Manufacturer
- ABBOTT MANUFACTURING, INC.
- Product Code
- JJE
- PMA / PMN Number
- K980367
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MO, US
- Reporter Occupation
- OTHER
Narratives
THE ABBOTT FIELD SERVICE REPRESENTATIVE WAS DISPATCHED TO INSPECT THE INSTRUMENT. THE R1 AND R2 SYRINGES WERE REBUILT, CONTROLS WERE RUN WITHOUT ISSUE. A 20-CUP PRECISION TEST WAS RUN WITH RESULTS WITHIN SPECIFICATIONS. ALSO, THE PVT (PERFORMANCE VERIFICATION TEST) WAS PERFORMED WITH ACCEPTABLE RESULTS. A DIFFERENCE IN RESULTS WAS OBSERVED BETWEEN SAMPLE CUPS AND SAMPLE TUBES. THE LABORATORY WATER SUPPLY WAS INSPECTED AND FOUND TO BE ACCEPTABLE. THE CARBON TANK, FILTER, AND UV LAMP WERE REPLACED. THE FIELD SERVICE REPRESENTATIVE CONFIGURED THE RETEST RULES FOR ALL CALCIUM RESULTS GREATER THAN 10.5 MG/DL. THE MIXERS WERE INSPECTED AND NO CHIPS OR CRACKS WERE OBSERVED. THE TEXT INDICATES THE SAMPLE PROBE HAD BEEN AN ISSUE WITH GEL ON THE PROBE AND CALIBRATION ISSUES. THE FIELD SERVICE REPRESENTATIVE CHECKED LIQUID LEVEL SENSE (LLS) VOLTAGES AND REPLACED THE LLS AND PRESSURE MONITORING BOARDS. THE CUSTOMER WAS UNAWARE OF THE MINIMUM SAMPLE REQUIREMENT LABEL ON THE ARCHITECT CARRIERS AND WAS UNABLE TO VERIFY IF ADEQUATE SAMPLE VOLUME ABOVE THE GEL BARRIER HAD BEEN PRESENT. REVIEW OF THE CENTRIFUGE TIMES REVEALED FOUR DIFFERENT CENTRIFUGES WERE USED, EACH WITH A DIFFERENT SPIN TIME FROM 5 MINUTES TO 10 MINUTES. THE CUSTOMER SUPPORT SPECIALIST REVIEWED WITH THE CUSTOMER THE RECOMMENDATIONS FROM GREINER BIO-ONE VACUETTES FOR SAMPLE PROCESSING PER PRODUCT INSERTS FROM THEIR WEBSITE. THE MANUFACTURER RECOMMENDS CENTRIFUGATION FOR 15 MINUTES AT 2000-3000G. THE CUSTOMER IS USING PLASTIC TUBES, GREINER BIO-ONE, 5 ML LITHIUM HEPARIN TUBES AND 6 ML SODIUM HEPARIN TUBES. THE CUSTOMER STATES THAT THE OPERATORS HAD COMMENTED ON THE OCCURRENCE OF FIBRIN IN PATIENT SAMPLES AND STATED THAT FREQUENT ASPIRATION ERRORS OCCUR, DUE TO FIBRIN IN THE SAMPLES. A REVIEW OF THE CUSTOMER'S SAMPLE HANDING PROCEDURES FOUND THAT SAMPLES COLLECTED BY THE PHLEBOTOMISTS ARE NOT FROM PATIENT'S HEPARIN LOCKS. THE CUSTOMER INDICATED THAT NONE OF THE SAMPLES WITH DISCREPANT RESULTS WERE RECENTRIFUGED AND TESTED. THIS IS AN INITIAL REPORT. AN INVESTIGATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE. END OF REPORT.
THE CUSTOMER STATES THAT ERRATIC PATIENT RESULTS ARE BEING GENERATED BY THE ARCHITECT C8000 CALCIUM ASSAY. THE CUSTOMER GAVE ONE EXAMPLE OF AN INITIAL RESULT OF 11.9 MG/DL THAT RETESTED AT 9.3 AND 17.7 MG/DL. THE CUSTOMER ALSO MENTIONED THAT A NURSE COMMENTED THAT OVER THE PAST WEEK PATIENT CALCIUM RESULTS SEEMED A LITTLE ELEVATED. UPON TROUBLESHOOTING, IT WAS DISCOVERED THAT THE CUSTOMER IS TOPPING OFF BOTH ACID AND ALKALINE WASH SOLUTIONS, SOMETIMES WHEN THE BOTTLE IS ONLY HALF FULL. THE CUSTOMER STATES THAT THEY DO THIS SO THAT THEY DO NOT HAVE TO STOP IN THE MIDDLE OF THE DAY TO REPLACE REAGENTS AND SUPPLIES. THE CTA ADVISED THE CUSTOMER TO REMOVE AND REPLACE THE WASH SOLUTIONS WITH NEW CONTAINERS AND SOLUTIONS ON BOTH ANALYZERS IN THE LAB AND TO DISCONTINUE THE PRACTICE OF TOPPING OFF SOLUTIONS. THE CUSTOMER AGREED. ALSO, THE CUSTOMER MENTIONED THAT THEY OFTEN HAVE ISSUES WITH FIBRIN IN THE PATIENT SAMPLES TO BE TESTED. THE CTA AND THE CUSTOMER REVIEWED THE CUSTOMER'S SAMPLE COLLECTION AND HANDLING PROCEDURES. A SERVICE CALL WAS ALSO INITIATED. THERE IS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ARCHITECT C8000 | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY ANALYZER | JJE | ABBOTT MANUFACTURING, INC. | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NI | CLINICAL CHEMISTRY CALCIUM ASSAY LIST# 7D61-20| LOT#: 59050HW00 |